{"id":"CHEMBL1023","canonicalSmiles":"C=C(c1ccc(C(=O)O)cc1)c1cc2c(cc1C)C(C)(C)CCC2(C)C","inchiKey":"NAVMQTYZDKMPEU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"BEXAROTENE","yearOfFirstApproval":1999,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Bexarotene","Targretin","Targretine"],"synonyms":["Bexarotene","LG-100069","LG100069","LGD-1069","LGD1069","NSC-747528"],"crossReferences":{"DailyMed":["bexarotene"],"PubChem":["124893633","144206219","144212724","170465308","50125754"],"Wikipedia":["Bexarotene"],"drugbank":["DB00307"],"chEBI":["50859"]},"linkedTargets":{"rows":["ENSG00000204231","ENSG00000143171","ENSG00000186350"],"count":3},"linkedDiseases":{"rows":["EFO_0000198","EFO_0000616","MONDO_0005090","MONDO_0002108","EFO_0002913","MONDO_0007254","EFO_0000222","EFO_1000100","EFO_1001110","EFO_1000747","EFO_0000305","EFO_0003060","EFO_0000565","MONDO_0015760","EFO_0003032","EFO_0004192","MONDO_0008903","MONDO_0004975","EFO_0000574","EFO_0000432","EFO_1001051","EFO_0000676","EFO_0001378","MONDO_0020077","EFO_1000785","EFO_0005411"],"count":26},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1999 and has 3 approved and 22 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1095282","canonicalSmiles":"CN(C)C(=O)OC1N=C(c2ccccc2)c2cc(Cl)ccc2N(C)C1=O","inchiKey":"PXBVEXGRHZFEOF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CAMAZEPAM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Albego","Camazepam","Limpidon","Paxor"],"crossReferences":{"Wikipedia":["Camazepam"],"drugbank":["DB01489"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL110094","canonicalSmiles":"CN(C)CCC=C1c2ccccc2C(C)(C)c2ccccc21","inchiKey":"GWWLWDURRGNSRS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MELITRACEN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Adelax","Melitracen"],"crossReferences":{"PubChem":["50125798"],"Wikipedia":["Melitracen"],"drugbank":["DB13384"]},"childChemblIds":["CHEMBL2107109"],"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL113142","canonicalSmiles":"Nc1nc(NCCc2ccc(O)cc2)nc2nc(-c3ccco3)nn12","inchiKey":"PWTBZOIUWZOPFT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ZM-241385","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ZM-241385"],"crossReferences":{"PubChem":["11113871","26752042"],"drugbank":["DB08770"]},"childChemblIds":["CHEMBL1628684"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1160945","canonicalSmiles":"O=C(O)[C@H](O)[C@H](O)COP(=O)(O)O","inchiKey":"ZCZXOHUILRHRQJ-PWNYCUMCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1160945","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03108"],"chEBI":["49003"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1184499","canonicalSmiles":"Cc1cc(C)[n+](CCc2ccc(S(N)(=O)=O)cc2)c(C)c1","inchiKey":"UXBCHTZINZNVRG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1184499","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04763"]},"childChemblIds":["CHEMBL352535"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1200386","canonicalSmiles":"CCOC(=O)O[C@]1(C(=O)COC(=O)CC)CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C","inchiKey":"FNPXMHRZILFCKX-KAJVQRHHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PREDNICARBATE","yearOfFirstApproval":1991,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Dermatop","Dermatop e emollient","Prednicarbate"],"synonyms":["HOE 777","HOE-777","LAS-189961","LAS-41003 COMPONENT PREDNICARBATE","LAS189961","NSC-760042","Prednicarbate","S 77 0777","S-77 0777","S-77-0777","S-770777"],"crossReferences":{"DailyMed":["prednicarbate"],"PubChem":["144204238","56463553"],"Wikipedia":["Prednicarbate"],"drugbank":["DB01130"]},"linkedTargets":{"rows":["ENSG00000113580"],"count":1},"linkedDiseases":{"rows":["EFO_0005854","EFO_0005539","EFO_0000685","HP_0000964","EFO_1001435","EFO_0000701","EFO_0003778","EFO_0001379","EFO_0000274","EFO_0007512","EFO_0002609","EFO_1001119","EFO_0000311","MONDO_0002026","HP_0004398","MP_0001845","MONDO_0002471","MONDO_0003937","MONDO_0002280","MONDO_0005301","EFO_0000676","EFO_0007141","EFO_0003833","MONDO_0005178"],"count":24},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1991 and has 20 approved and 4 investigational indications."}
{"id":"CHEMBL1200511","canonicalSmiles":"CC(=O)O.CC(C)C[C@H](NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)NCC(N)=O","inchiKey":"NGCGMRBZPXEPOZ-HBBGHHHDSA-N","drugType":"Protein","blackBoxWarning":false,"name":"GONADORELIN ACETATE","yearOfFirstApproval":1989,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1007","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cystorelin","Factrel","GnRH","Gonadotropin Releasing Hormone","Lh Releasing Factor","Lutrelef","Lutrepulse","Lutrepulse kit"],"synonyms":["ABBOTT-41070","Fertagyl","Gonadorelin acetate","Gonadorelin acetate mixture","Gonadorelin diacetate","Hypocrine","Luteinizing","Luteinizing hormone-releasing factor diacetate tetrahydrate"],"linkedTargets":{"rows":["ENSG00000109163"],"count":1},"linkedDiseases":{"rows":["MONDO_0002146","EFO_0000545","EFO_1001757","EFO_0000731","MONDO_0007254","EFO_0000673","MONDO_0008315","Orphanet_478","MONDO_0018555","EFO_0001663"],"count":10},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1989 and has 8 investigational indications."}
{"id":"CHEMBL1200592","canonicalSmiles":"CC(C)(C)C(=O)OCC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C","inchiKey":"VVOIQBFMTVCINR-WWMZEODYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DESOXYCORTICOSTERONE PIVALATE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Percorten"],"synonyms":["Desoxycorticosterone pivalate","Desoxycorticosterone trimethylacetate"],"crossReferences":{"PubChem":["144205152"],"drugbank":["DB01134"],"chEBI":["50782"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1200805","canonicalSmiles":"COc1ccc([C@@H]2Sc3ccccc3N(CCN(C)C)C(=O)[C@@H]2OC(C)=O)cc1.O=C(O)CC(O)C(=O)O","inchiKey":"IUSFTUWHKCSCDY-BHDTVMLSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DILTIAZEM MALATE","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL23","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Tiamate"],"synonyms":["Diltiazem malate","MK-793"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1996."}
{"id":"CHEMBL1200964","canonicalSmiles":"CN(C)CCC=C1c2ccccc2CCc2ccccc21.Cl","inchiKey":"KFYRPLNVJVHZGT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"AMITRIPTYLINE HYDROCHLORIDE","yearOfFirstApproval":1961,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL629","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Amitid","Amitril","Amitriptyline hydrochloride","Cytriptyline","Domical","Elavil","Endep","Lentizol","Limbitrol 5","Saroten","Saroten retard","Triptafen","Triptafen-m","Tryptizol","Tryptizol-75"],"synonyms":["Amitriptyline hcl","Amitriptyline hydrochloride","Amitriptylini hydrochloridum","Etravil","NIH 10794","NSC-104210","Novoprotect","Syneudon"],"crossReferences":{"DailyMed":["amitriptyline%20hydrochloride"],"PubChem":["144206673","144208476","144213917","170464758","17389180","26747443","26751626","49816669","50105841","855970"]},"linkedTargets":{"rows":["ENSG00000108576","ENSG00000103546"],"count":2},"linkedDiseases":{"rows":["HP_0000989","EFO_0003761","EFO_0009387"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1961 and is indicated for unipolar depression and has 2 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201108","canonicalSmiles":"Cc1nc2c([nH]1)CCN(C(=O)c1ccc(NC(=O)c3ccccc3-c3ccccc3)cc1)c1ccccc1-2.Cl","inchiKey":"BTYHAFSDANBVMJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CONIVAPTAN HYDROCHLORIDE","yearOfFirstApproval":2005,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1755","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Vaprisol"],"synonyms":["CI-1025","Conivaptan hcl","Conivaptan hydrochloride","YM-087","YM087"],"crossReferences":{"chEBI":["31430"]},"linkedTargets":{"rows":["ENSG00000126895","ENSG00000166148"],"count":2},"linkedDiseases":{"rows":["HP_0002902","EFO_0003144","EFO_0001421"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2005 and is indicated for heart failure and has 2 investigational indications."}
{"id":"CHEMBL1201127","canonicalSmiles":"CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@@H]12)S(=O)(=O)c1ccc(N)cc1.CCO","inchiKey":"QWSHKNICRJHQCY-VBTXLZOXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DARUNAVIR ETHANOLATE","yearOfFirstApproval":2006,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1323","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Prezista"],"synonyms":["Darunavir (as ethanolate)","Darunavir Ethanolate","Darunavir ethanolate","Darunavir monoethanolate","Rezolsta","Tmc114 ethanolate"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2006 and has 4 approved indications."}
{"id":"CHEMBL1201136","drugType":"Small molecule","blackBoxWarning":false,"name":"TITANIUM DIOXIDE","yearOfFirstApproval":2006,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Dundee","E45 sun","Reflectant"],"synonyms":["C.i. 77891","CI-(1975)NO.77891","Ci 77891","Ci-77891","Ci-pigment white 6","E 171","E-171","E171","INS NO.171","INS-171","NSC-15204","NSC-200C","Rutile","Rutile (tio2)","Sagenite","Titania","Titanium dioxide","Titanium oxide","Titanium peroxide"],"crossReferences":{"PubChem":["124898737"],"Wikipedia":["Titanium_dioxide"],"chEBI":["32234"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2006 and is indicated for sunburn and skin cancer and has 2 investigational indications."}
{"id":"CHEMBL1201193","canonicalSmiles":"CCCCN1CCCC[C@H]1C(=O)Nc1c(C)cccc1C","inchiKey":"LEBVLXFERQHONN-INIZCTEOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LEVOBUPIVACAINE","yearOfFirstApproval":1999,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["(-)-bupivacaine","(s)-bupivacaine","Bupivacaine (-)-form","Bupivacaine, (-)-","Bupivacaine, (s)-","L-bupivacaine","Levobupivacaine","Novabupi"],"crossReferences":{"PubChem":["11112642","29215441"],"Wikipedia":["Levobupivacaine"],"drugbank":["DB01002"],"chEBI":["6149"]},"childChemblIds":["CHEMBL1200749"],"linkedTargets":{"rows":["ENSG00000007314"],"count":1},"linkedDiseases":{"rows":["EFO_0000668","EFO_0000616","EFO_0011061","EFO_0005323","EFO_1000631","EFO_0009085","MONDO_0007254","HP_0000175","EFO_0000284","EFO_0009387","HP_0003418","EFO_0003843","EFO_0002950","EFO_0003964","EFO_0000537","HP_0002027","HP_0100543","EFO_1002012","HP_0001822","EFO_0003833","EFO_0009676","MONDO_0005178","HP_0000023","EFO_1001792","EFO_0005251"],"count":25},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1999 and has 7 investigational indications."}
{"id":"CHEMBL1201487","drugType":"Enzyme","blackBoxWarning":false,"name":"SACROSIDASE","yearOfFirstApproval":1998,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Sucraid"],"synonyms":[".beta.-fructofuranosidase","Sacrosidase"],"crossReferences":{"DailyMed":["sacrosidase"],"DrugCentral":["5043"],"Wikipedia":["Sacrosidase"]},"description":"Enzyme drug with a maximum clinical trial phase of IV that was first approved in 1998."}
{"id":"CHEMBL1201534","drugType":"Unknown","blackBoxWarning":false,"name":"DANAPAROID SODIUM","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Orgaran"],"synonyms":["Danaparoid","Danaparoid sodium","ORG 10172","ORG-10172","Sodium danaparoid"],"linkedTargets":{"rows":["ENSG00000117601"],"count":1},"linkedDiseases":{"rows":["HP_0004419","HP_0001873"],"count":2},"description":"Unknown drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and is indicated for recurrent thrombophlebitis and has 1 investigational indication."}
{"id":"CHEMBL1201656","drugType":"Protein","blackBoxWarning":false,"name":"INSULIN SUSP ISOPHANE PURIFIED PORK","yearOfFirstApproval":1979,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Insulin insulatard nph nordisk","Nph iletin ii (pork)","Nph purified pork isophane insulin"],"synonyms":["Insulin susp isophane purified pork"],"description":"Protein drug with a maximum clinical trial phase of IV that was first approved in 1979."}
{"id":"CHEMBL1201765","canonicalSmiles":"CC(C)C(=O)Oc1ccc(CO)cc1[C@H](CCN(C(C)C)C(C)C)c1ccccc1.O=C(O)/C=C/C(=O)O","inchiKey":"MWHXMIASLKXGBU-RNCYCKTQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FESOTERODINE FUMARATE","yearOfFirstApproval":2008,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201764","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Fesoterodine fumarate","Toviaz"],"synonyms":["Fesoterodine fumarate","SPM 8272","SPM 907","SPM-8272","SPM-907"],"crossReferences":{"DailyMed":["fesoterodine%20fumarate"]},"linkedTargets":{"rows":["ENSG00000133019","ENSG00000181072"],"count":2},"linkedDiseases":{"rows":["EFO_0006865","HP_0000020","EFO_1000781"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2008 and is indicated for urgency urinary incontinence and overactive bladder and has 1 investigational indication."}
{"id":"CHEMBL1201835","drugType":"Antibody","blackBoxWarning":false,"name":"USTEKINUMAB","yearOfFirstApproval":2009,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Stelara","Stelera"],"synonyms":["CNTO 1275","CNTO-1275","TT-20","Ustekinumab","Ustekinumab "],"crossReferences":{"DailyMed":["ustekinumab"],"DrugCentral":["4966"],"Wikipedia":["Ustekinumab"]},"linkedTargets":{"rows":["ENSG00000113302"],"count":1},"linkedDiseases":{"rows":["EFO_0000729","EFO_1001494","EFO_1000710","EFO_0003780","MONDO_0019269","EFO_0003778","EFO_0000274","EFO_0000540","EFO_1001486","Orphanet_247353","EFO_0002690","EFO_0000676","EFO_0003921","Orphanet_797","MONDO_0013730","EFO_0000685","EFO_1001857","EFO_0003898","MONDO_0044881","EFO_0000384","EFO_0002609","EFO_0007187","EFO_1001209","EFO_1001231","MONDO_0005301","EFO_0000398","MONDO_0005147","Orphanet_99842","EFO_0003872"],"count":29},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2009 and has 5 approved and 21 investigational indications."}
{"id":"CHEMBL1204165","canonicalSmiles":"C[C@H](CCc1ccccc1)NC[C@H](O)c1ccc(O)c(C(N)=O)c1.Cl","inchiKey":"WQVZLXWQESQGIF-WJKBNZMCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DILEVALOL HYDROCHLORIDE","yearOfFirstApproval":1990,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL27193","hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United Kingdom"],"classes":["Hepatotoxicity"],"year":1990},"tradeNames":[],"synonyms":["Dilevalol hcl","Dilevalol hydrochloride","SCH 19927","SCH-19927"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1990. It was withdrawn in United Kingdom  in 1990 due to Hepatotoxicity."}
{"id":"CHEMBL1234965","canonicalSmiles":"CCCCCCCCCC(=O)CC(=O)N[C@H]1CCNC1=O","inchiKey":"VEYZCVBECUYIJZ-AWEZNQCLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1234965","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08323"],"chEBI":["44612"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1236802","canonicalSmiles":"[Xe]","inchiKey":"FHNFHKCVQCLJFQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"XENON","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Xenon"],"crossReferences":{"drugbank":["DB13453"],"chEBI":["49957"]},"childChemblIds":["CHEMBL1200673","CHEMBL1200685","CHEMBL4594411"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1982 and has 13 investigational indications."}
{"id":"CHEMBL1237070","canonicalSmiles":"CCCCCOc1ccc(-c2cc(-c3ccc(C(=O)N[C@H]4C[C@@H](O)[C@@H](O)NC(=O)[C@@H]5[C@@H](O)[C@@H](C)CN5C(=O)[C@H]([C@H](O)CC(N)=O)NC(=O)[C@H]([C@H](O)[C@@H](O)c5ccc(O)c(OS(=O)(=O)[O-])c5)NC(=O)[C@@H]5C[C@@H](O)CN5C(=O)[C@H]([C@@H](C)O)NC4=O)cc3)no2)cc1.[Na+]","inchiKey":"KOOAFHGJVIVFMZ-WZPXRXMFSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"MICAFUNGIN SODIUM","yearOfFirstApproval":2005,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL457547","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Fungard","Micafungin","Mycamine"],"synonyms":["FK-463","FK463","Funguard","Micafungin na","Micafungin sodium","Micafungin sodium salt"],"crossReferences":{"DailyMed":["micafungin%20sodium"],"chEBI":["80105"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2005 and is indicated for candidiasis and has 3 investigational indications."}
{"id":"CHEMBL1255840","canonicalSmiles":"CC1(C)CCC(NC(=O)[C@@H](N)CCC(=O)O)CC1","inchiKey":"VCRGLZYPNNAVRP-JTQLQIEISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NEBOGLAMINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cr2249","Neboglamine","Nebostinel","XY-2401"],"crossReferences":{"PubChem":["144204806","50106666","90341776"]},"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL1332971","canonicalSmiles":"Cc1c(Cl)cccc1Nc1ncccc1C(=O)O","inchiKey":"CLOMYZFHNHFSIQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CLONIXIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Clonixin","NSC-335505","SCH 10304","SCH-10304"],"crossReferences":{"PubChem":["144205329","29216065","50086862"],"drugbank":["DB09218"],"chEBI":["76200"]},"childChemblIds":["CHEMBL4303711","CHEMBL1729342"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL136145","canonicalSmiles":"C[N+](C)(C)CCS","inchiKey":"VFUGTBZQGUVGEX-UHFFFAOYSA-O","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL136145","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01803"]},"childChemblIds":["CHEMBL147699"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1370","canonicalSmiles":"CCCC1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1","inchiKey":"VOVIALXJUBGFJZ-KWVAZRHASA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"BUDESONIDE","yearOfFirstApproval":1994,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aircort","Budeflam aquanase","Budelin novolizer","Budenofalk","Budesonide","Cortiment","Duoresp spiromax","Entocort","Entocort cr","Entocort ec","Ortikos","Preferid","Pulmaxan","Pulmicort","Pulmicort flexhaler","Pulmicort l.s.","Pulmicort respules","Rhinocort","Rhinocort allergy","Rhinocort aqua","Rhinocort aqua 64","Symbicort","Uceris"],"synonyms":["Budesonide","MAP-0010","MAP0010","NSC-757788","R01AD05","S-1320"],"crossReferences":{"DailyMed":["budesonide"],"PubChem":["56422168","855541","90341081"],"Wikipedia":["Budesonide"],"drugbank":["DB01222"],"chEBI":["3207"]},"linkedTargets":{"rows":["ENSG00000113580"],"count":1},"linkedDiseases":{"rows":["EFO_0000729","EFO_0007486","EFO_0007183","EFO_0000756","EFO_0000464","MONDO_0007254","MONDO_0005271","EFO_0010638","EFO_0009657","EFO_1000637","EFO_1001486","EFO_0003882","EFO_1001293","HP_0004798","HP_0002043","EFO_0005676","Orphanet_70589","EFO_1001223","EFO_1001295","MONDO_0008903","Orphanet_786","EFO_1001417","HP_0025267","EFO_0005628","EFO_0005854","MONDO_0013730","EFO_0000694","EFO_0008521","EFO_0008572","HP_0002014","EFO_0008590","EFO_1001294","EFO_0009661","EFO_0007140","EFO_1000782","EFO_0004194","EFO_1002029","EFO_0004599","EFO_0000384","HP_0001742","HP_0002110","EFO_0004232","HP_0006536","EFO_0004268","MONDO_0100096","EFO_1000391","EFO_0000684","EFO_0006505","MONDO_0004979","EFO_1001411","EFO_0000341","HP_0025428","EFO_0003918","EFO_0003956"],"count":54},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1994 and has 11 approved and 32 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1378","canonicalSmiles":"CCSc1ccc2c(c1)N(CCCN1CCN(C)CC1)c1ccccc1S2","inchiKey":"XCTYLCDETUVOIP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"THIETHYLPERAZINE","yearOfFirstApproval":1961,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Thiethylperazine","Torecan"],"crossReferences":{"Wikipedia":["Thiethylperazine"],"drugbank":["DB00372"],"chEBI":["9544"]},"childChemblIds":["CHEMBL3989478","CHEMBL2359670","CHEMBL1326247","CHEMBL1201074","CHEMBL1200856"],"linkedTargets":{"rows":["ENSG00000149295"],"count":1},"linkedDiseases":{"rows":["MONDO_0004975","MONDO_0005271"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1961 and is indicated for allergic disease and has 2 investigational indications."}
{"id":"CHEMBL13828","canonicalSmiles":"O=c1[nH]c2ccccc2n1CCCN1CCN(C(c2ccccc2)c2ccccc2)CC1","inchiKey":"BAINIUMDFURPJM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OXATOMIDE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Tinset"],"synonyms":["Celtect","Cobiona","Dasten","NSC-309710","Oxatomide","R 35,443","R-35443"],"crossReferences":{"PubChem":["11111579","144203770","170466059","50100302","50106789","50106790","85231171","855791"],"Wikipedia":["Oxatomide"],"drugbank":["DB12877"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for allergic disease and has 1 investigational indication."}
{"id":"CHEMBL139423","canonicalSmiles":"O=C(O)C(=O)Nc1sc2c(c1C(=O)O)CCSC2","inchiKey":"ZPDVRWNOCOREGF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL139423","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02072"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1413176","canonicalSmiles":"Cc1c(NC(=O)c2cccnc2)c(=O)n(-c2ccccc2)n1C","inchiKey":"BRZANEXCSZCZCI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NIFENAZONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["N-antipyrinylnicotinamide","NSC-758411","Niapyrin","Nicophezon","Nifenazone"],"crossReferences":{"PubChem":["11112511","144204070","170466050","26666234","26748748"],"drugbank":["DB13407"]},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL1530581","canonicalSmiles":"c1ccc2sc(SN3CCOCC3)nc2c1","inchiKey":"MHKLKWCYGIBEQF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1530581","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144204527","170465568","3717542","50105063"],"drugbank":["DB14202"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1534","canonicalSmiles":"Cc1cc2nc3c(=O)[nH]c(=O)nc-3n(C[C@H](O)[C@H](O)[C@H](O)CO)c2cc1C","inchiKey":"AUNGANRZJHBGPY-SCRDCRAPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RIBOFLAVIN","yearOfFirstApproval":1993,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["E-b2","Flavaxin","Freeda","Riboflavine","Vitamin B 2","Vitamin G"],"synonyms":["Bisulase","C.i. 50900","C.i. food yellow 15","E-101(iii)","E101","INS NO. 101(I)","Ins no.101(iii)","Ins-101(iii)","Lacto-flavin","Lactoflavin","NCI-0033298","NSC-33298","Riboflavin","Riboflavin (vit b2)","Riboflavin tetrabutyrate","Riboflavinum","Russupteridine yellow iii","Vitamin b-2","Vitamin b2","Vitamin b2 (as riboflavin)","Vitamin g","Vitamin-b2"],"crossReferences":{"PubChem":["144204364","144205267","144208831","144213297","170465063","17389635"],"drugbank":["DB00140"],"chEBI":["17015"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1993 and has 5 approved and 15 investigational indications."}
{"id":"CHEMBL1567328","canonicalSmiles":"COc1ccc2[n-]c([S+]([O-])Cc3ncc(C)c(OC)c3C)nc2c1.COc1ccc2[n-]c([S+]([O-])Cc3ncc(C)c(OC)c3C)nc2c1.[Mg+2]","inchiKey":"KWORUUGOSLYAGD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OMEPRAZOLE MAGNESIUM","yearOfFirstApproval":2003,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1503","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Omeprazole magnesium","Prilosec","Prilosec otc"],"synonyms":["H 168/68 MAGNESIUM","Omeprazole (as magnesium)","Omeprazole magnesium","Omeprazole magnesium salt"],"crossReferences":{"DailyMed":["omeprazole%20magnesium"],"PubChem":["49665950","49681830"]},"linkedTargets":{"rows":["ENSG00000105675"],"count":1},"linkedDiseases":{"rows":["EFO_0003948"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2003 and has 1 investigational indication."}
{"id":"CHEMBL1572050","canonicalSmiles":"CCCCCCCCCCC(CO)CCCCCCCC","inchiKey":"LEACJMVNYZDSKR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OCTYLDODECANOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-2405","Octyldodecanol"],"crossReferences":{"PubChem":["144212611","170465533","29217971"],"drugbank":["DB14134"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1604","canonicalSmiles":"CC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)[C@H](N)C3=CCC=CC3)[C@H]2SC1","inchiKey":"RDLPVSKMFDYCOR-UEKVPHQBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEPHRADINE","yearOfFirstApproval":1974,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Anspor","Cefradine","Cephradine","Ecosporina","Nicef","Velosef","Velosef '125'","Velosef '250'","Velosef '500'"],"synonyms":["Cefradine","Cefradine hydrate","Cephradine","Cephradine anhydrous","Cephradine hydrate","Cephradine, unspecified hydrate","NSC-756672","SK&F D-39304","SK-D-39304","SQ 11436","SQ 22022 [DIHYDRATE]","SQ-11436","SQ-22022"],"crossReferences":{"PubChem":["144207037","170465355"],"Wikipedia":["Cefradine"],"drugbank":["DB01333"],"chEBI":["3547"]},"childChemblIds":["CHEMBL4303427"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1974 and is indicated for bacterial disease."}
{"id":"CHEMBL1614641","canonicalSmiles":"C[C@H](C(=O)O)c1ccc2oc(-c3ccc(F)cc3)nc2c1","inchiKey":"ARPYQKTVRGFPIS-VIFPVBQESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLUNOXAPROFEN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Flunoxaprofen"],"crossReferences":{"Wikipedia":["Flunoxaprofen"],"drugbank":["DB13317"],"chEBI":["76154"]},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1679","canonicalSmiles":"Nc1nc(=O)c2c([nH]1)NCC(CNc1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1)N2C=O","inchiKey":"VVIAGPKUTFNRDU-ABLWVSNPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LEUCOVORIN","yearOfFirstApproval":1952,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Leucovorin"],"crossReferences":{"DailyMed":["leucovorin%20calcium"],"Wikipedia":["Folinic_acid"],"drugbank":["DB00650"],"chEBI":["15640"]},"childChemblIds":["CHEMBL3184463","CHEMBL3707260","CHEMBL1201138"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1952 and has 114 investigational indications."}
{"id":"CHEMBL1721515","canonicalSmiles":"O=C(O)CN1CCN(CC(=O)O)CCN(CC(=O)O)CCN(CC(=O)O)CC1","inchiKey":"WDLRUFUQRNWCPK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TETRAXETAN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["DOT-A","DOTA","Dota acid","NSC-681107","Tetraxetan"],"crossReferences":{"PubChem":["518671","56320897"],"chEBI":["61028"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL1725880","canonicalSmiles":"CCOc1cc(OCC)c(C(=O)CCC(=O)O)cc1OCC","inchiKey":"YPTFHLJNWSJXKG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TREPIBUTONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Supacal","Trepibutone"],"crossReferences":{"PubChem":["144206005","170465772","50112702"],"drugbank":["DB13311"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1734","canonicalSmiles":"O=C(O[C@H]1CN2CCC1CC2)N1CCc2ccccc2[C@@H]1c1ccccc1","inchiKey":"FBOUYBDGKBSUES-VXKWHMMOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SOLIFENACIN","yearOfFirstApproval":2004,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Vesicare"],"synonyms":["NSC-759144","Solifenacin"],"crossReferences":{"DailyMed":["solifenacin%20succinate"],"PubChem":["50113280"],"Wikipedia":["Solifenacin"],"drugbank":["DB01591"]},"childChemblIds":["CHEMBL1200803","CHEMBL2361425"],"linkedTargets":{"rows":["ENSG00000133019","ENSG00000181072"],"count":2},"linkedDiseases":{"rows":["HP_0000103","EFO_0003103","EFO_0006865","HP_0000020","HP_0001268","EFO_1000781","EFO_0000284","EFO_0004710","HP_0011277"],"count":9},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2004 and has 4 approved and 3 investigational indications."}
{"id":"CHEMBL1892201","canonicalSmiles":"CCCCC1C(=O)NN(c2ccccc2)C1=O","inchiKey":"REOJLIXKJWXUGB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MOFEBUTAZONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Mofebutazone","Monazone","Monophenylbutazone","NSC-73725"],"crossReferences":{"PubChem":["89855698"],"drugbank":["DB13629"],"chEBI":["76252"]},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL190044","canonicalSmiles":"CCC(COC(=O)c1cc(OC)c(OC)c(OC)c1)(c1ccccc1)N(C)C","inchiKey":"LORDFXWUHHSAQU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRIMEBUTINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Trimebutine","Trimebutine maleate"],"crossReferences":{"Wikipedia":["Trimebutine"],"drugbank":["DB09089"]},"childChemblIds":["CHEMBL1325297"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1908335","canonicalSmiles":"CC(C)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2ccccc2)N(C)C(=O)[C@H](CCSCC(=O)NC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(N)=O)NC1=O","inchiKey":"XXXSJQLZVNKRKX-YQRDHHIGSA-N","drugType":"Protein","blackBoxWarning":false,"name":"DEPREOTIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Depreotide","P-829","P829"],"crossReferences":{"drugbank":["DB11628"]},"description":"Protein drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1996652","canonicalSmiles":"CC[N+](C)(CC)CCOC(=O)C(O)(c1ccccc1)c1ccccc1","inchiKey":"HDAMOICMOAXFLJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHYLBENACTYZIUM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Diethyllachesine","Methylbenactyzium cation","Methylbenactyzium ion"],"crossReferences":{"PubChem":["50125792"],"drugbank":["DB13181"]},"childChemblIds":["CHEMBL2106570"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2029605","canonicalSmiles":"CC(C)[C@@H]1NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC1=O","inchiKey":"JXPWLIYXIWGWSA-CLBRJLNISA-N","drugType":"Protein","blackBoxWarning":false,"name":"LIVOLETIDE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AZP 531","AZP-531","Azp-531","Livoletide"],"crossReferences":{"drugbank":["DB15188"]},"description":"Protein drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL203125","canonicalSmiles":"O=CN(O)CCCP(=O)(O)O","inchiKey":"GJXWDTUCERCKIX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FOSMIDOMYCIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fosmidomycin"],"crossReferences":{"PubChem":["174006643"],"Wikipedia":["Fosmidomycin"],"drugbank":["DB02948"],"chEBI":["443725"]},"childChemblIds":["CHEMBL2164257"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL205821","canonicalSmiles":"CC(C)[C@H](NC(=O)OCc1ccccc1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)CF","inchiKey":"SUUHZYLYARUNIA-YEWWUXTCSA-N","drugType":"Protein","blackBoxWarning":false,"name":"CHEMBL205821","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07744"]},"description":"Protein drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2074972","canonicalSmiles":"COC(=O)C1=C(C)NC(C)=C(C(=O)OC2CCCN(Cc3ccccc3)C2)C1c1cccc([N+](=O)[O-])c1","inchiKey":"QZVNQOLPLYWLHQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BENIDIPINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Benidipine","Benidipine hydrochloride"],"linkedTargets":{"rows":["ENSG00000157388","ENSG00000081248","ENSG00000151067","ENSG00000102001"],"count":4},"linkedDiseases":{"rows":["EFO_0003884","EFO_0000319"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2103737","drugType":"Small molecule","blackBoxWarning":false,"name":"HYDROXOCOBALAMIN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Alpharedisol","Cobalin-h","Cyanokit","Hepavit","Hydroxocobalamin","Hydroxomin","Megamilbedoce","Neo-cytamen"],"synonyms":["Hydroxocobalamin","Hydroxocobalamin acetate","Hydroxocobalamin anhydrous","Hydroxocobalaminum anhydrous","Hydroxocobemine","Hydroxycobalamin"],"crossReferences":{"DailyMed":["hydroxocobalamin"],"DrugCentral":["4309","4644"],"chEBI":["27786"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for acne and anemia (phenotype) and has 2 investigational indications."}
{"id":"CHEMBL2103764","canonicalSmiles":"CO/N=C(\\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(C)CS[C@H]12)c1csc(N)n1","inchiKey":"MQLRYUCJDNBWMV-GHXIOONMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEFETAMET","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cefetamet","Cefetamet pivoxil hydrochloride","Deacetoxycefotaxime","LY-097964","LY-97964","LY097964","RO 15-8074","RO-15-8074"],"crossReferences":{"drugbank":["DB13504"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2103823","canonicalSmiles":"O=C([N-]S(=O)(=O)c1ccc(Br)s1)c1ccc(Cl)cc1Cl.[Na+]","inchiKey":"JCOHXVDKRMWUQP-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"TASISULAM SODIUM","maximumClinicalTrialPhase":3,"parentId":"CHEMBL2110587","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LY-573636 SODIUM","LY-573636.NA","LY-573636NA","Tasisulam sodium"],"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2103996","canonicalSmiles":"CNCC(=O)c1ccc(O)c(O)c1","inchiKey":"PZMVOUYYNKPMSI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ADRENALONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Adrenalone","Adrenone","NSC-243611"],"crossReferences":{"PubChem":["144206663","170466247","99494755"],"drugbank":["DB13394"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2104574","canonicalSmiles":"CCCCC[C@H](O)/C=C/[C@@H]1C(CCCCCCC(=O)OCCCC)=C(OC(=O)CCC)C[C@H]1O","inchiKey":"HITYEEHTEOQBAC-OSIGYOHNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ECRAPROST","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AS-013","Circulase","Ecraprost"],"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2105242","canonicalSmiles":"CCN(CC)c1nc(=NN)nc(N(CC)CC)[nH]1","inchiKey":"IRQOBYXMACIFKD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MELADRAZINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BA 13155 [AS TARTRATE]","Hydramitrazine","Meladrazine","NSC-99857"],"crossReferences":{"drugbank":["DB13272"]},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2105322","canonicalSmiles":"O=C(O)CSC(SCC(=O)O)SCC(=O)O","inchiKey":"ZBNBQISDCFIEQC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RITIOMETAN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ritiometan"],"crossReferences":{"drugbank":["DB13267"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2106277","canonicalSmiles":"C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@H]1C(=O)COC(=O)C(C)(C)C","inchiKey":"UWGRWFCLGQWKPR-GSTUPEFVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIFLUCORTOLONE PIVALATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Diflucortolone pivalate","SH 968","SH-968"],"crossReferences":{"drugbank":["DB14664"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2106978","canonicalSmiles":"O=C([O-])[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.[K+]","inchiKey":"HLCFGWHYROZGBI-JJKGCWMISA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"POTASSIUM GLUCONATE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Kaon","Katorin"],"synonyms":["D-gluconic acid potassium salt","E-577","Gluconic acid potassium salt","INS NO.577","INS-577","Kali gluconicum","Monopotassium d-gluconate","Potassium d-gluconate","Potassium gluconate"],"crossReferences":{"DrugCentral":["4524"],"PubChem":["144209972"],"drugbank":["DB13620"]},"description":"Small molecule drug with a maximum clinical trial phase of IV and has 1 investigational indication."}
{"id":"CHEMBL2107359","canonicalSmiles":"CONC(=N)c1ccc(-c2ccc(-c3ccc(C(=N)NOC)cc3)o2)cc1.O=C(O)/C=C\\C(=O)O","inchiKey":"SWMNGXODFOCPKQ-BTJKTKAUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PAFURAMIDINE MALEATE","maximumClinicalTrialPhase":3,"parentId":"CHEMBL319669","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["DB-289","DB289","Pafuramidine maleate"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2107729","canonicalSmiles":"O=C(Nc1ccc(S(=O)(=O)N2CCOCC2)cc1)c1cc(Cl)ccc1NS(=O)(=O)c1ccc(Cl)s1","inchiKey":"PQHLRGARXNPFCF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ATACIGUAT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ataciguat"],"crossReferences":{"PubChem":["144206754","170466340"],"drugbank":["DB12805"]},"childChemblIds":["CHEMBL4079827"],"linkedTargets":{"rows":["ENSG00000164116","ENSG00000061918","ENSG00000123201","ENSG00000152402"],"count":4},"linkedDiseases":{"rows":["EFO_0000266","EFO_0003876","EFO_0003843"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2107821","canonicalSmiles":"NCC[C@@H](O)c1cccc(OCC2CCCCC2)c1","inchiKey":"WJIGGYYSZBWCGC-MRXNPFEDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EMIXUSTAT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Acu-4429"],"synonyms":["ACU-4429","Emixustat"],"crossReferences":{"drugbank":["DB12608"]},"childChemblIds":["CHEMBL2107829"],"linkedTargets":{"rows":["ENSG00000116745"],"count":1},"linkedDiseases":{"rows":["EFO_1001492","EFO_0001365","Orphanet_827","EFO_0009322"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2108318","drugType":"Protein","blackBoxWarning":false,"name":"ELSIGLUTIDE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Elsiglutide","ZP-1846","ZP1846","Zp1846"],"linkedTargets":{"rows":["ENSG00000065325"],"count":1},"linkedDiseases":{"rows":["HP_0002014"],"count":1},"description":"Protein drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2108322","drugType":"Protein","blackBoxWarning":false,"name":"VATREPTACOG ALFA (ACTIVATED)","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NN-1731","NN1731","Vatreptacog alfa","Vatreptacog alfa (activated)"],"description":"Protein drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2108811","drugType":"Antibody","blackBoxWarning":false,"name":"VISILIZUMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Nuvion"],"synonyms":["HUM-291","Visilizumab","huM291"],"linkedTargets":{"rows":["ENSG00000198851"],"count":1},"linkedDiseases":{"rows":["MONDO_0013730","EFO_0000729","MONDO_0000956","EFO_0000574","EFO_0000222","EFO_0000384","EFO_0004599"],"count":7},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL2108918","drugType":"Unknown","blackBoxWarning":false,"name":"CHAMOMILE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["B2045","Blue chamomile flower","Chamomile","Chamomile flower, german","Chamomile flowers","Chamomile tea","Chamomile whole","Chamomilla","Chamomilla chamomilla flower","Chamomilla flower","Chamomilla recutita flower","Chamomilla vulgaris flower","Chamomilla whole","German chamomile","German chamomile flower","German chamomile whole","Hungarian chamomile flower","Hungarian chamomile whole","Matricaria chamomilla","Matricaria chamomilla flower","Matricaria flower","Matricaria recutita","Matricaria recutita flower","Matricaria recutita flower dry extract","Matricaria recutita flower extract","Matricaria recutita l. flower","Matricaria suaveolens flower","Matricaria whole","Matricariae flos","Mayweed flower","Pineapple weed whole","Scented mayweed flower","Scented mayweed whole","Sweet false chamomile flower","Sweet false chamomile whole","True chamomile flower","True chamomile whole","Wild chamomile flower","Wild chamomile whole"],"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL2109247","drugType":"Antibody","blackBoxWarning":false,"name":"LBY-135","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LBY-135"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2109352","drugType":"Antibody","blackBoxWarning":false,"name":"BL22","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BL22","Bl22","CAT-3888"],"linkedTargets":{"rows":["ENSG00000012124"],"count":1},"linkedDiseases":{"rows":["EFO_0000565","EFO_1000956","EFO_0000574"],"count":3},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2141296","canonicalSmiles":"CC(C)C[C@H](NC(=O)CNC(=O)c1cc(Cl)ccc1Cl)B(O)O","inchiKey":"MXAYKZJJDUDWDS-LBPRGKRZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IXAZOMIB","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ninlaro"],"synonyms":["Ixazomib","MLN-2238","MLN-9708 FREE BASE","MLN2238"],"crossReferences":{"PubChem":["124955652"],"drugbank":["DB09570"]},"linkedTargets":{"rows":["ENSG00000100804"],"count":1},"linkedDiseases":{"rows":["EFO_0009441","EFO_0000616","MONDO_0000873","EFO_0005761","EFO_0000220","EFO_0000681","EFO_1000314","EFO_0000222","EFO_1001469","EFO_1001264","MONDO_0044881","Orphanet_85443","EFO_0000311","EFO_0006738","EFO_0000565","EFO_0007160","EFO_0005537","EFO_0000764","EFO_0003884","EFO_0000574","EFO_0001378","MONDO_0018906","MONDO_0020743"],"count":23},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for cancer and neoplasm and has 19 investigational indications."}
{"id":"CHEMBL21536","canonicalSmiles":"CCCCCCOc1nsnc1C1=CCCN(C)C1","inchiKey":"JOLJIIDDOBNFHW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"XANOMELINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LY-246708","LY-246708 FREE BASE","LY246708","Xanomeline"],"crossReferences":{"Wikipedia":["Xanomeline"],"drugbank":["DB15357"],"chEBI":["10056"]},"childChemblIds":["CHEMBL2336050","CHEMBL73149"],"linkedTargets":{"rows":["ENSG00000180720","ENSG00000168539"],"count":2},"linkedDiseases":{"rows":["MONDO_0005090"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2179105","canonicalSmiles":"C[C@@H]1CN(Cc2ncccn2)C[C@H]1c1nc2c(cnn2C2CCOCC2)c(=O)[nH]1","inchiKey":"IWXUVYOOUMLUTQ-CZUORRHYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PF-04447943","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pf-04447943"],"crossReferences":{"drugbank":["DB11953"]},"linkedTargets":{"rows":["ENSG00000160191"],"count":1},"linkedDiseases":{"rows":["MONDO_0004975"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL24171","canonicalSmiles":"COc1c2ccoc2cc2oc(=O)ccc12","inchiKey":"BGEBZHIAGXMEMV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BERGAPTEN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["5-methoxypsoralen","Bergaptan","Bergapten","Bergaptene","Geralen","Heraclin","Majudin","Methoxsalen related compound a","NSC-95437"],"crossReferences":{"PubChem":["11113276","144209555","144213572","17389221","26747383","400239","50105624","85148739"],"Wikipedia":["Bergapten"],"drugbank":["DB12216"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for psoriasis and has 1 investigational indication."}
{"id":"CHEMBL245416","canonicalSmiles":"N[C@@H](Cn1ccc(=O)c(O)c1)C(=O)O","inchiKey":"WZNJWVWKTVETCG-YFKPBYRVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"L-MIMOSINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["L-Mimosine"],"crossReferences":{"PubChem":["90340685"],"drugbank":["DB01055"],"chEBI":["29063"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL255066","canonicalSmiles":"CCOC(=O)COc1ccc2c(C)c(CCN(CC)CC)c(=O)oc2c1Cl","inchiKey":"GYNNRVJJLAVVTQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CLORICROMEN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cloricromen"],"crossReferences":{"PubChem":["29217526","50111702"],"Wikipedia":["Cloricromen"],"drugbank":["DB13367"]},"childChemblIds":["CHEMBL2354840"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL263881","canonicalSmiles":"CCN(CC)C(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1","inchiKey":"VAYOSLLFUXYJDT-RDTXWAMCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LYSERGIDE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LSD","Lsd-25","Lysergic acid diethylamide","Lysergic acid diethylamide tartrate ci","Lysergide","N,n-diethyllysergamide"],"crossReferences":{"PubChem":["144206425","144207057","50113078"],"Wikipedia":["Lysergic_acid_diethylamide"],"drugbank":["DB04829"],"chEBI":["6605"]},"childChemblIds":["CHEMBL463207","CHEMBL269421"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL27577","canonicalSmiles":"NC(=O)c1ccccc1O","inchiKey":"SKZKKFZAGNVIMN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SALICYLAMIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-3115","Salicylamide"],"crossReferences":{"PubChem":["144204680","144209142","144213118","170465496","17389647","26747354","8139933"],"Wikipedia":["Salicylamide"],"drugbank":["DB08797"],"chEBI":["32114"]},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL278398","canonicalSmiles":"CN1CCC2=C(C1)C(c1ccccc1)c1ccccc12","inchiKey":"ISFHAYSTHMVOJR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHENINDAMINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["NU-1504","Nolahist","Phenindamine","Thephorin"],"crossReferences":{"Wikipedia":["Phenindamine"],"drugbank":["DB01619"],"chEBI":["8065"]},"childChemblIds":["CHEMBL2107213"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for allergic disease."}
{"id":"CHEMBL3039511","canonicalSmiles":"COc1cc(CNCCC2CCOCC2)ccc1Oc1cnc(C(N)=O)cn1","inchiKey":"ZGCYVRNZWGUXNQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BEVENOPRAN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ADL-5945","ADL5945","Bevenopran","CB-5945","CB5-945","CB5945"],"crossReferences":{"drugbank":["DB12464"]},"linkedTargets":{"rows":["ENSG00000112038"],"count":1},"linkedDiseases":{"rows":["EFO_0003086","HP_0002019"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3137333","canonicalSmiles":"CNCC(=O)OCc1cccnc1N(C)C(=O)OC(C)[n+]1cnn(C[C@](O)(c2cc(F)ccc2F)[C@@H](C)c2nc(-c3ccc(C#N)cc3)cs2)c1.O=S(=O)([O-])O","inchiKey":"LWXUIUUOMSMZKJ-KLFWAVJMSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"ISAVUCONAZONIUM SULFATE","yearOfFirstApproval":2015,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1183349","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cresemba"],"synonyms":["AK-1820","AK1820","Ak1820","BAL-8557-002","BAL8557-002","Isavuconazonium sulfate"],"crossReferences":{"DailyMed":["isavuconazonium%20sulfate"],"chEBI":["85977"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2015 and is indicated for mucormycosis and aspergillosis and has 2 investigational indications."}
{"id":"CHEMBL3187723","canonicalSmiles":"Cn1cnc2c(F)c(Nc3ccc(Br)cc3F)c(C(=O)NOCCO)cc21","inchiKey":"ACWZRVQXLIRSDF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BINIMETINIB","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Mektovi"],"synonyms":["ARRY 438162","ARRY-162","ARRY-438162","Binimetinib","MEK-162","MEK162","Mek-162","NVP-MEK162"],"crossReferences":{"DailyMed":["binimetinib"],"PubChem":["174006430"],"drugbank":["DB11967"]},"linkedTargets":{"rows":["ENSG00000126934","ENSG00000169032"],"count":2},"linkedDiseases":{"rows":["EFO_0000756","EFO_0002503","EFO_1000657","MONDO_0007254","EFO_0001071","MONDO_0021063","MONDO_0002087","EFO_0000305","EFO_1001951","EFO_0000565","EFO_1001480","MONDO_0002158","EFO_1000044","EFO_1000956","EFO_0000389","MONDO_0008903","EFO_0002617","EFO_0000616","EFO_0002618","EFO_0000685","EFO_1000616","EFO_1000069","MONDO_0008170","Orphanet_44890","EFO_0000313","EFO_0003060","EFO_0000311","EFO_0000304","EFO_0002892","EFO_0001421","EFO_0001378","MONDO_0024880","EFO_0003833","MONDO_0021637"],"count":34},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2018 and has 5 approved and 21 investigational indications."}
{"id":"CHEMBL3301598","canonicalSmiles":"COc1cnc(-n2cnc(C)n2)c2c1c(C(=O)C(=O)N1CCN(C(=O)c3ccccc3)CC1)cn2COP(=O)(O)O.NC(CO)(CO)CO","inchiKey":"RRGJSMBMTOKHTE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FOSTEMSAVIR TROMETHAMINE","yearOfFirstApproval":2020,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL3301594","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Rukobia"],"synonyms":["BMS-663068-03","Fostemsavir trometamol","Fostemsavir tromethamine","GSK-3684934A","GSK3684934A"],"crossReferences":{"DailyMed":["fostemsavir%20tromethamine"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2020 and is indicated for hiv-1 infection and immunodeficiency disease."}
{"id":"CHEMBL3301667","canonicalSmiles":"[Ca+2].[N-]=C=[N-]","inchiKey":"MYFXBBAEXORJNB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CALCIUM CARBIMIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL116583","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Calcium carbimide","Carbodimid calcium","Cyanamide","Cyanamide calcium salt (1:1)","NSC-7078","Nitrolime"],"crossReferences":{"DrugCentral":["4432"],"drugbank":["DB09116"],"chEBI":["64301"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3354594","canonicalSmiles":"CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCCSC[C@@H](C(=O)N(CC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)Cc2ccc(F)cc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O","inchiKey":"PVVHQWISMVJHFK-NIFJBHDKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3354594","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB12932"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3358920","canonicalSmiles":"O=C(O)C[C@H]1CCc2c1[nH]c1ccc(OCc3ccc(C4CCCC4)c(C(F)(F)F)c3)cc21","inchiKey":"MVGWUTBTXDYMND-QGZVFWFLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETRASIMOD","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["APD-334","APD-334(FREE ACID)","APD334","Apd334","Etrasimod"],"crossReferences":{"drugbank":["DB14766"]},"childChemblIds":["CHEMBL3989933"],"linkedTargets":{"rows":["ENSG00000170989"],"count":1},"linkedDiseases":{"rows":["EFO_0004232","EFO_0000729","EFO_0004192","HP_0000999","EFO_0000274","EFO_1001486","EFO_0000384","EFO_0003767"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 8 investigational indications."}
{"id":"CHEMBL341273","canonicalSmiles":"Clc1cccc(Nc2nc(OCC3CCCCC3)c3[nH]cnc3n2)c1","inchiKey":"OUEGMEMDEAOAEG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL341273","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07203"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL342672","canonicalSmiles":"N=C(N)NCCC[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)[C@@H](NC=O)CNC(=O)/C=C/[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](Cc2ccccc2)NC(=O)C1=O","inchiKey":"CDWXSPKJKIUEQF-BIXWYCRZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CYCLOTHEONAMIDE A","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04269"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545216","drugType":"Small molecule","blackBoxWarning":false,"name":"FX-005","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fx-005"],"linkedTargets":{"rows":["ENSG00000112062"],"count":1},"linkedDiseases":{"rows":["EFO_0004616"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3545283","canonicalSmiles":"CN1CCC(c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)C1CO","inchiKey":"QLUYMIVVAYRECT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RIVICICLIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["P 276-00 free base","P-276-00 free base","P276-00","Riviciclib"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL3545349","canonicalSmiles":"Cc1nccn1Cc1cc(-c2ccc(F)c(C(F)F)c2)cnn1.Cl.Cl","inchiKey":"OJBLXSPBJMGZDN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EVT-101","maximumClinicalTrialPhase":2,"parentId":"CHEMBL3545350","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Evt-101","Evt101"],"crossReferences":{"drugbank":["DB05956"]},"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL3545400","drugType":"Small molecule","blackBoxWarning":false,"name":"SAR-103168","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Sar-103168"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL358866","canonicalSmiles":"CC(=O)N[C@@H](Cc1ccc(C(=O)O)c(C=O)c1)C(=O)N[C@H]1CCCCN(Cc2ccc(-c3ccccc3)cc2)C1=O","inchiKey":"WKTQBTSOHBKBRW-VMPREFPWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL358866","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03268"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL36342","canonicalSmiles":"CCCCCCCCN=c1ccn(CCCCCCCCCCn2ccc(=NCCCCCCCC)cc2)cc1.Cl.Cl","inchiKey":"SMGTYJPMKXNQFY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OCTENIDINE HYDROCHLORIDE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL1199480","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LAS-189962","LAS189962","Octenidine","Octenidine dihydrochloride","Octenidine hcl","Octenidine hydrochloride","Sensidin do","WIN 41464-2","WIN-41464-2"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL367149","canonicalSmiles":"CC/C=C\\C/C=C\\C/C=C\\C/C=C\\C/C=C\\C/C=C\\CCC(=O)O","inchiKey":"MBMBGCFOFBJSGT-KUBAVDMBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DOCONEXENT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["22:6 n-3","C22:6 (n-3)","Cervonic acid","Doconexent","Docosaheaenoic-acid","Docosahexaenoic acid","Docosahexaenoic acid (c22:6 n3)","Docosahexanoic acid","Omega-3 marine triglycerides"],"crossReferences":{"PubChem":["144205545","26754926","26754927","26754928","50110834"],"Wikipedia":["Docosahexaenoic_acid"],"drugbank":["DB03756"],"chEBI":["28125"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 45 investigational indications."}
{"id":"CHEMBL3707330","canonicalSmiles":"C[C@@H](OC[C@@]1(c2ccccc2)CC[C@]2(CCC(=O)N2)CN1)c1cc(C(F)(F)F)cc(C(F)(F)F)c1.Cl.O","inchiKey":"GZQWMYVDLCUBQX-WVZIYJGPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ROLAPITANT HYDROCHLORIDE","yearOfFirstApproval":2015,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL3707331","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Varubi"],"synonyms":["Rolapitant hcl h20","Rolapitant hydrochloride","Rolapitant hydrochloride monohydrate","SCH-619734","SCH619734"],"crossReferences":{"DailyMed":["rolapitant%20hydrochloride"]},"linkedTargets":{"rows":["ENSG00000115353"],"count":1},"linkedDiseases":{"rows":["EFO_0006911","EFO_0000691"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2015 and is indicated for chemotherapy-induced nausea and vomiting and has 1 investigational indication."}
{"id":"CHEMBL384200","canonicalSmiles":"CCCCCCCCCCCCCCCCCCCCCCCCCC(=O)N[C@@H](CO[C@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O)[C@H](O)[C@H](O)CCCCCCCCCCCCCC","inchiKey":"VQFKFAKEUMHBLV-BYSUZVQFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RGI-7000","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[".alpha.-galcer","AGL-582","Alpha-galactosylceramide","KRN-7000","KRN7000","Krn7000","RGI-7000","Rgi-7000"],"crossReferences":{"drugbank":["DB12232"],"chEBI":["466659"]},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL3884248","canonicalSmiles":"Cc1ncc([N+](=O)[O-])n1CC(O)CN1CCOCC1","inchiKey":"GAZGHCHCYRSPIV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MORINIDAZOLE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Morinidazole","Morponidazole"],"crossReferences":{"drugbank":["DB15098"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3989695","canonicalSmiles":"CNC(=O)c1cnn(-c2nc(N)c3ncn([C@@H]4O[C@H](CO)[C@@H](O)[C@H]4O)c3n2)c1.O","inchiKey":"CDQVVPUXSPZONN-WPPLYIOHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"REGADENOSON","yearOfFirstApproval":2008,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL317052","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Lexiscan"],"synonyms":["CVT-3146","Rapiscan","Regadenoson"],"crossReferences":{"DailyMed":["regadenoson"]},"linkedTargets":{"rows":["ENSG00000128271"],"count":1},"linkedDiseases":{"rows":["EFO_0000319"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2008 and is indicated for cardiovascular disease."}
{"id":"CHEMBL3989867","canonicalSmiles":"O=C(NCc1c(F)cc(F)cc1F)c1cn2c(c([O-])c1=O)C(=O)N1[C@H]3CC[C@H](C3)O[C@@H]1C2.[Na+]","inchiKey":"WJNFBIVCQMPPJC-FQYDJHLKSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"BICTEGRAVIR SODIUM","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL3989866","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Bictegravir sodium","GS-9883","GS-9883-01"],"crossReferences":{"DailyMed":["bictegravir%20sodium"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2018 and is indicated for hiv-1 infection."}
{"id":"CHEMBL3990028","drugType":"Antibody","blackBoxWarning":false,"name":"BLESELUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ASKP-1240","ASKP1240","Bleselumab"],"linkedTargets":{"rows":["ENSG00000101017"],"count":1},"linkedDiseases":{"rows":["EFO_0000676","EFO_0004236"],"count":2},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL405957","canonicalSmiles":"OC[C@@H]1N[C@@H](CO)[C@H](O)[C@H]1O","inchiKey":"PFYHYHZGDNWFIF-BXKVDMCESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL405957","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02172"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL424133","canonicalSmiles":"Cc1ccc(Cn2nc(CCCc3ccc(OC(C)(C)C(=O)O)cc3)nc2O)cc1","inchiKey":"PNHFDVSKDSLUFH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LY-518674","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["KB-68984","LY-674","LY518674","Ly-518674"],"crossReferences":{"drugbank":["DB12988"]},"linkedTargets":{"rows":["ENSG00000186951"],"count":1},"linkedDiseases":{"rows":["EFO_0000195","HP_0003124","EFO_0000537"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL427683","canonicalSmiles":"COc1ccc(C)c(OC(CCN2CCC(n3c(=O)[nH]c4ccccc43)CC2)C(C)C)c1","inchiKey":"HDTXDTWVQLQAMW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ORGANON","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Organon"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4289017","canonicalSmiles":"CC(=O)NCC(=O)N1[C@H]2CC[C@@H]1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12","inchiKey":"RYYNGWLOYLRZLK-RBUKOAKNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL4289017","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB13059"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4297317","canonicalSmiles":"C[C@@H](C(N)=O)[C@H](N)c1nc2ccc(C(C)(C)C)cc2[nH]1","inchiKey":"APWZIFIAVVFPNT-PELKAZGASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PF-06305591","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PF-6305591","Pf-06305591"],"crossReferences":{"drugbank":["DB12106"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4297428","canonicalSmiles":"CC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(N)=O","inchiKey":"GJLXVWOMRRWCIB-MERZOTPQSA-N","drugType":"Protein","blackBoxWarning":false,"name":"SER-100","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ac-ryyrwkkkkkkk-nh2","SER100","Ser-100","Ser100","ZP 120","Zp-120"],"description":"Protein drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297526","canonicalSmiles":"COC(=O)CC[C@@H]1N=C(c2ccccn2)c2cc(Br)ccc2-n2c(C)cnc21","inchiKey":"CYHWMBVXXDIZNZ-KRWDZBQOSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"REMIMAZOLAM","yearOfFirstApproval":2020,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Byfavo"],"synonyms":["CNS 7056","CNS-7056","Cns 7056","ONO-2745","Remimazolam"],"crossReferences":{"DailyMed":["remimazolam%20besylate"],"drugbank":["DB12404"]},"childChemblIds":["CHEMBL4297324","CHEMBL4594301"],"linkedTargets":{"rows":["ENSG00000022355","ENSG00000182256","ENSG00000011677","ENSG00000163285","ENSG00000151834","ENSG00000113327","ENSG00000186297"],"count":7},"linkedDiseases":{"rows":["EFO_0003890","EFO_0001645","EFO_0001421","EFO_0004888","MONDO_0000870","EFO_0009267","EFO_0005230","EFO_0003843","EFO_0005251"],"count":9},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2020 and has 4 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL4297857","drugType":"Unknown","blackBoxWarning":false,"name":"ETRUMADENANT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AB-928","AB928","Ab-928","Ab928","Etrumadenant"],"linkedTargets":{"rows":["ENSG00000170425","ENSG00000128271"],"count":2},"linkedDiseases":{"rows":["EFO_1001480","EFO_1000044","EFO_1000657","EFO_0000673","EFO_0003060","MONDO_0008315","EFO_1001951"],"count":7},"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4298184","drugType":"Antibody","blackBoxWarning":false,"name":"MAFTIVIMAB","yearOfFirstApproval":2020,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Maftivimab","Maftivimab-ebgn","REGN3479","Regn-3479"],"description":"Antibody drug with a maximum clinical trial phase of IV that was first approved in 2020 and is indicated for ebola hemorrhagic fever."}
{"id":"CHEMBL4594346","drugType":"Protein","blackBoxWarning":false,"name":"AMLISIMOD","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Amlisimod","SDP-4","Silk-derived protein-4"],"description":"Protein drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4594524","drugType":"Unknown","blackBoxWarning":false,"name":"TRIS(8-HYDROXYQUINOLINATO)GALLIUM","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AP-002","Ap-002","Gallium, tris(8-quinolinolato)-","IT-235","LX-001","NKP-2235","NSC-158197","Tris(8-hydroxyquinolinato)gallium"],"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4594529","drugType":"Antibody","blackBoxWarning":false,"name":"NURULIMAB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Anti-ctla4 mab (biocad)","BCD-145","BCD145","Bcd-145","Nurulimab"],"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4594564","drugType":"Antibody","blackBoxWarning":false,"name":"TESNATILIMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["IPH- 2301","IPH-2301","JNJ-4500","JNJ-64304500","Jnj-64304500","NN-8555","NN8555","NNC-0142-0000-0002","NNC-0142-0002","NNC142-0002","Tesnatilimab"],"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL46423","canonicalSmiles":"CC(C)c1cccc(C(C)C)c1NC(=O)NCC1(c2ccc(N(C)C)cc2)CCCC1","inchiKey":"PKKNCEXEVUFFFI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NEVANIMIBE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Nevanimibe","PD 132301","PD-132301"],"childChemblIds":["CHEMBL542103"],"linkedTargets":{"rows":["ENSG00000057252"],"count":1},"linkedDiseases":{"rows":["EFO_0003099","EFO_1000796","Orphanet_418"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4650277","canonicalSmiles":"CC(C)(C)NCCNc1ccc(C2=NN=C(C(F)(F)F)C2)nc1C1CCN(c2ncnc3c2C(C)(C)C(=O)N3)CC1","inchiKey":"UVKWCPOZHXNKAZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TAS0612","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["TAS0612","Tas0612"],"linkedTargets":{"rows":["ENSG00000072133","ENSG00000117676","ENSG00000175634","ENSG00000071242","ENSG00000177189","ENSG00000105221","ENSG00000117020","ENSG00000108443","ENSG00000142208"],"count":9},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4650278","canonicalSmiles":"CCN(C(=O)c1cc(F)ccc1Oc1cncnc1N1CC2(CCN(C[C@H]3CC[C@H](NS(=O)(=O)CC)CC3)CC2)C1)C(C)C.CCN(C(=O)c1cc(F)ccc1Oc1cncnc1N1CC2(CCN(C[C@H]3CC[C@H](NS(=O)(=O)CC)CC3)CC2)C1)C(C)C.O=C(O)/C=C/C(=O)O.O=C(O)/C=C/C(=O)O.O=C(O)/C=C/C(=O)O","inchiKey":"AXNUWYROYVRYIM-OQIJCFCCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SNDX-5613","maximumClinicalTrialPhase":1,"parentId":"CHEMBL4650827","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SNDX-5613","Sndx-5613"],"linkedTargets":{"rows":["ENSG00000133895","ENSG00000118058"],"count":2},"linkedDiseases":{"rows":["EFO_0000220","MONDO_0020743"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4650442","drugType":"Unknown","blackBoxWarning":false,"name":"ANX-005","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ANX-005","ANX005","Anx-005","Anx005"],"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL479","canonicalSmiles":"CSc1ccc2c(c1)N(CCC1CCCCN1C)c1ccccc1S2","inchiKey":"KLBQZWRITKRQQV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"THIORIDAZINE","yearOfFirstApproval":1962,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United Kingdom"," Worldwide"],"classes":["Cardiotoxicity"],"year":2005},"tradeNames":["Mellaril","Mellaril-s","Melleril","Rideril"],"synonyms":["Dl-thioridazine","Mellaril","Mellerette","Novoridazine","Sonapax","TP-21","Thioridazine","Thioridazine prolongatum","Thioril"],"crossReferences":{"DailyMed":["thioridazine%20hydrochloride"],"PubChem":["104171257","124881748","144203845","170465080","174006671","26752322","50105272","90341630"],"TG-GATEs":["38"],"Wikipedia":["Thioridazine"],"drugbank":["DB00679"],"chEBI":["9566"]},"childChemblIds":["CHEMBL1200916"],"linkedTargets":{"rows":["ENSG00000069696","ENSG00000149295","ENSG00000102468","ENSG00000151577","ENSG00000147246"],"count":5},"linkedDiseases":{"rows":["MONDO_0005090","MONDO_0002050","HP_0000726","EFO_0000222","EFO_0005407","EFO_0005230","EFO_0005411"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1962 and is indicated for psychosis and has 5 investigational indications. It was withdrawn in United Kingdom and  Worldwide initially in 2005 due to Cardiotoxicity. This drug has a black box warning from the FDA."}
{"id":"CHEMBL4802180","drugType":"Unknown","blackBoxWarning":false,"name":"RECOMBINANT HUMAN THROMBOPOIETIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Recombinant human thrombopoietin"],"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL481958","canonicalSmiles":"CC(=O)[C@]1(N)Cc2c(O)c3c(c(O)c2[C@@H](O[C@H]2C[C@H](O)[C@H](O)CO2)C1)C(=O)c1ccccc1C3=O.Cl","inchiKey":"BHMLHEQFWVQAJS-IITOGVPQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMRUBICIN HYDROCHLORIDE","maximumClinicalTrialPhase":3,"parentId":"CHEMBL1186894","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Amrubicin hydrochloride","Calsed","SM 5887","SM-5887"],"linkedTargets":{"rows":["ENSG00000131747"],"count":1},"linkedDiseases":{"rows":["MONDO_0008903","EFO_0000702"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL486208","canonicalSmiles":"CC1(C)[C@@H]2CC[C@@]1(C)[C@@H](O)C2","inchiKey":"DTGKSKDOIYIVQL-WEDXCCLWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BORNEOL","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(-) Borneol","2-borneol","Bingpian","Borneol","Borneol, dl-","Borneolum syntheticum","Camphol","Endo-borneol","FEMA NO. 2157","Hechenglongnao","NSC-60223"],"crossReferences":{"Wikipedia":["Borneol"],"chEBI":["15393"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL48802","canonicalSmiles":"C[S+]([O-])CCCCN=C=S","inchiKey":"SUVMJBTUFCVSAD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SULFORAPHANE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(-)-sulforaphane","(r)-sulforaphane","4-(Methylsulfinyl)Butyl Isothiocyanate","Sulforaphane","Sulforaphane, (r)-"],"crossReferences":{"Wikipedia":["Sulforaphane"],"chEBI":["47807"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 13 investigational indications."}
{"id":"CHEMBL493287","canonicalSmiles":"N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O","inchiKey":"MSWZFWKMSRAUBD-IVMDWMLBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GLUCOSAMINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Chitosamine","Glucosamine","Mediflex"],"crossReferences":{"drugbank":["DB01296"],"chEBI":["47977"]},"childChemblIds":["CHEMBL3989618","CHEMBL3989750","CHEMBL3989707","CHEMBL1707007"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for rheumatic disease and has 6 investigational indications."}
{"id":"CHEMBL494480","canonicalSmiles":"CCN(CC)C(=O)c1ccc(C2=CC3(CCNCC3)Oc3cccc(O)c32)cc1","inchiKey":"OPIKUXLJQFYMSC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ADL-5859","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Adl-5859"],"crossReferences":{"PubChem":["174006844"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL501867","canonicalSmiles":"CC[C@]1(O)C[C@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C=O)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1.O=S(=O)(O)O","inchiKey":"AQTQHPDCURKLKT-JKDPCDLQSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"VINCRISTINE SULFATE","yearOfFirstApproval":1963,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL90555","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Kyocristine","Leurocristine Sulfate","Marqibo kit","Oncovin","Vincasar","Vincasar pfs","Vincrex","Vincristine sulfate","Vincristine sulfate pfs"],"synonyms":["37231","Kyocristine","LILLY-37231","Marqibo","NSC-67574","Novopharm","Vincristine sulfate","Vincristine sulfate liposome","Vincristine sulphate","Vincristini sulfas","Vincrisul"],"crossReferences":{"PubChem":["112141"],"chEBI":["79401"]},"linkedTargets":{"rows":["ENSG00000261456","ENSG00000188229","ENSG00000104833","ENSG00000137267","ENSG00000258947","ENSG00000101162","ENSG00000137285","ENSG00000196230","ENSG00000176014"],"count":9},"linkedDiseases":{"rows":["MONDO_0000873","EFO_0004708","EFO_0000558","EFO_0000756","EFO_1000131","EFO_0005952","EFO_1001951","EFO_0000565","EFO_0000309","EFO_1001935","EFO_0000588","EFO_0000096","MONDO_0002974","HP_0001871","MONDO_0019088","MONDO_0008903","MONDO_0015540","EFO_0002918","EFO_0000094","Orphanet_654","EFO_0009441","EFO_1000292","EFO_0000220","MONDO_0018271","EFO_0000248","EFO_0002939","Orphanet_636","EFO_1001946","EFO_1001365","MONDO_0044889","EFO_0003032","MONDO_0044917","EFO_0000574","EFO_0001378","MONDO_0009348","MONDO_0019471","Orphanet_790","EFO_1001469","EFO_0000209","MONDO_0003541","EFO_0000272","EFO_0004289","MONDO_0020743","EFO_0000183","MONDO_0002618","MONDO_0002083","EFO_1000158","MONDO_0000430","EFO_0000616","EFO_0000765","EFO_1000616","EFO_0006859","EFO_0000437","EFO_0000403","EFO_1001042","MONDO_0000870","EFO_0000313","EFO_0000222","EFO_0000621","EFO_0000211","EFO_0000095","EFO_0000174","EFO_0005235","EFO_1001936","EFO_1001947","MONDO_0002367","MONDO_0018906","EFO_0003833","EFO_0000691","MONDO_0021637"],"count":70},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1963 and has 56 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL520642","canonicalSmiles":"Nc1nc(/C(=N/O)C(=O)N[C@@H]2C(=O)N3C(C(=O)O)=C(/C=C4\\CCN([C@@H]5CCNC5)C4=O)CS[C@H]23)ns1","inchiKey":"VOAZJEPQLGBXGO-SDAWRPRTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEFTOBIPROLE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BAL-9141-000","BAL-9141000","BAL9141-000","Ceftobiprole","RO 63-9141","RO-63-9141","RO-639141","Zeftera","Zevtera"],"crossReferences":{"Wikipedia":["Ceftobiprole"],"drugbank":["DB04918"]},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL523","canonicalSmiles":"O=C1CN=C(c2ccccc2)c2cc(Cl)ccc2N1","inchiKey":"AKPLHCDWDRPJGD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NORDAZEPAM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Calmday","Madar","Stilny","Vegesan"],"synonyms":["Calmday","Demadar","Desmethyldiazepam","Desoxydemoxepam","Madar","N-desmethyldiazepam","NSC-46078","NSC-631619","Nordazepam","Nordazepam civ","Nordiazepam","Praxadium","RO 5-2180"],"crossReferences":{"PubChem":["144207042","49647614"],"Wikipedia":["Nordazepam"],"drugbank":["DB14028"],"chEBI":["111762"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL594840","canonicalSmiles":"CC(C)(C)c1onc(OCP(=O)(O)O)c1C[C@H](N)C(=O)O","inchiKey":"AGSOOCUNMTYPSE-ZETCQYMHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL594840","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02347"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL69308","canonicalSmiles":"CC(C(=O)O)c1ccc(/C=C2\\CCCCC2=O)cc1","inchiKey":"AUZUGWXLBGZUPP-GXDHUFHOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PELUBIPROFEN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CS-670","Pelubiprofen","RS-2131"],"crossReferences":{"PubChem":["124894216","144206823"],"drugbank":["DB12150"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL70663","canonicalSmiles":"Cc1cc(C)c(Nc2ccnc(Nc3ccc(C#N)cc3)n2)c(C)c1","inchiKey":"ILAYIAGXTHKHNT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DAPIVIRINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AIDS-105293","Dapivirine","Gel-02","R-147681","TMC-120"],"crossReferences":{"drugbank":["DB08639"]},"childChemblIds":["CHEMBL1257032"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL74415","canonicalSmiles":"CCCCCc1cc(O)c2c(c1)OC(C)(C)c1ccc(C)cc1-2","inchiKey":"VBGLYOIFKLUMQG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CANNABINOL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cannabinol","NSC-134455"],"crossReferences":{"PubChem":["144207035"],"Wikipedia":["Cannabinol"],"drugbank":["DB14737"],"chEBI":["3360"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 44 investigational indications."}
{"id":"CHEMBL839","canonicalSmiles":"CC(C)(C)NCC(O)COc1cccc2c1CCC(=O)N2","inchiKey":"LWAFSWPYPHEXKX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CARTEOLOL","yearOfFirstApproval":1988,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Carteolol","Cartrol","Ocupress"],"crossReferences":{"DailyMed":["carteolol%20hydrochloride"],"Wikipedia":["Carteolol"],"drugbank":["DB00521"],"chEBI":["3437"]},"childChemblIds":["CHEMBL1201002"],"linkedTargets":{"rows":["ENSG00000169252","ENSG00000043591","ENSG00000188778"],"count":3},"linkedDiseases":{"rows":["EFO_0004190","EFO_0000319","EFO_0000516"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1988 and has 3 approved indications."}
